KURA ONCOLOGY INC. - COMMON STOCK

Kura Oncology to Report Second Quarter 2021 Financial Results

29 7 2021 16:05:01 提供 Nasdaq GlobeNewswire

Kura Oncology Appoints Helen Collins, M.D. to Board of Directors

29 7 2021 07:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology Announces Clinical Collaboration to Evaluate Tipifarnib in Combination with Alpelisib in Head and Neck Squamous Cell Carcinoma

06 7 2021 07:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology Doses First Patient in Phase 1b Expansion Cohorts with Menin Inhibitor KO-539

24 6 2021 08:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology to Participate in JMP Securities Life Sciences Conference

10 6 2021 07:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology Appoints Carol Schafer to Board of Directors

04 6 2021 07:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology to Participate in Cowen Virtual Oncology Innovation Summit

13 5 2021 07:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology Reports First Quarter 2021 Financial Results

06 5 2021 16:04:00 提供 Nasdaq GlobeNewswire

Kura Oncology to Report First Quarter 2021 Financial Results

29 4 2021 07:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology Announces Publication of Tipifarnib Phase 2 Data in Journal of Clinical Oncology

22 3 2021 16:08:47 提供 Nasdaq GlobeNewswire

Kura Oncology Reports Fourth Quarter and Full Year 2020 Financial Results

24 2 2021 07:20:00 提供 Nasdaq GlobeNewswire

Kura Oncology Receives FDA Breakthrough Therapy Designation for Tipifarnib in Head and Neck Squamous Cell Carcinoma

24 2 2021 07:00:00 提供 Nasdaq GlobeNewswire

Kura Oncology to Participate in Four Upcoming Investor Conferences

18 2 2021 07:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology to Report Fourth Quarter and Full Year 2020 Financial Results

17 2 2021 07:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology to Participate in H.C. Wainwright BioConnect 2021 Conference

07 1 2021 07:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology to Present at J.P. Morgan Healthcare Conference

06 1 2021 07:30:00 提供 Nasdaq GlobeNewswire